Jarro-Dophilus Baby By Jarrow Formulas Overview & Drug Interactions
Check For Interactions With Jarro-Dophilus Baby
Supplement: Jarro-Dophilus Baby by Jarrow Formulas
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Probiotic Blend
Ingredient Group | Blend (non-nutrient/non-botanical) |
---|---|
Category | blend |
-
B. breve M-16V
Ingredient Group Bifidobacterium breve Category bacteria
B. longum BB536
Ingredient Group Bifidobacterium longum Category bacteria
L. casei R0215
Ingredient Group Lactobacillus casei Category bacteria
L. rhamnosus Lr-32
Ingredient Group Lactobacillus rhamnosus Category bacteria
B. bifidum Bb-02
Ingredient Group Bifidobacterium bifidum Category bacteria
B. lactis BI-04
Ingredient Group Bifidobacterium animalis lactis Category bacteria
Galacto-oligosaccharides
Ingredient Group | Galactooligosaccharides |
---|---|
Category | complex carbohydrate |
Drugs that interact with Jarro-Dophilus Baby by Jarrow Formulas
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
Label Information
Supplement Facts:
Daily Value (DV) Target Group(s): | Infants |
---|---|
Minimum serving Sizes: |
0.25 Teaspoon(s)
|
Maximum serving Sizes: |
0.25 Teaspoon(s)
|
Servings per container | 71 |
UPC/BARCODE | 790011030133 |
Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
---|---|---|---|
Probiotic Blend |
22.9 mg
|
Blend (non-nutrient/non-botanical) |
--
|
B. breve M-16V |
0 NP
|
Bifidobacterium breve |
|
B. longum BB536 |
0 NP
|
Bifidobacterium longum |
|
L. casei R0215 |
0 NP
|
Lactobacillus casei |
|
L. rhamnosus Lr-32 |
0 NP
|
Lactobacillus rhamnosus |
|
B. bifidum Bb-02 |
0 NP
|
Bifidobacterium bifidum |
|
B. lactis BI-04 |
0 NP
|
Bifidobacterium animalis lactis |
|
Galacto-oligosaccharides |
600 mg
|
Galactooligosaccharides |
--
|
Other Ingredients: |
Tapioca Starch
Vitamin C
|
---|
Label Statments:
Suggested/Recommended/Usage/Directions |
- Usage: Up to age 4, mix 1/4 teaspoon per day in water, juice, lukewarm infant formula or food, or as directed by your qualified healthcare professional. For newborns, mix into formula only 1/16 teaspoon per day for the first week. Do not feed powder directly to infants or children.
|
---|---|
Precautions |
- Do not feed powder directly to infants or children.
- Keep out of the reach of children.
- Contains: Milk and soy (in trace amounts).
|
Formula |
- Jarro-Dophilus Baby contains B. breve M-16V and B. longum BB536, probiotics clinically documented for babies. GOS, like human milk oligosaccharides, supports beneficial Bifidobacteria colonization in intestines.
- Probiotic + GOS Prebiotic
|
Storage |
- Keep refrigerated.
- Fridge
Keep refrigerated
|
FDA Disclaimer Statement |
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
|
Formulation |
- Minimum 3 billion viable cells at time of consumption, under recommended storage conditions and within Best Used Before date
- 3 billion CFU guaranteed
With clinically documented strains
- Note: Color of product naturally varies from white to tan.
|
Seals/Symbols |
- IPRO
|
General Statements |
- 33+ Years
Probiotic Pioneer
Since 1986
|
FDA Statement of Identity |
- Probiotic Supplement
|
Brand IP Statement(s) |
- Copyright 2021 Jarrow Formulas
|
Brand Information
See all products by this brand
Distributed exclusively by | |
---|---|
Name | Jarrow Formulas |
City | Los Angeles |
State | CA |
ZipCode | 90035-4317 |
Phone Number | 1-866-459-4154 |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.